[Private prescriptions of hypnotics and tranquilizers for statutory health-insured patients: regulatory framework versus reality of primary care]

MeSH terms

• Antidepressive Agents / adverse effects
• Antidepressive Agents / therapeutic use
• Antipsychotic Agents / adverse effects
• Antipsychotic Agents / therapeutic use
• Azabicyclo Compounds / adverse effects
• Azabicyclo Compounds / therapeutic use
• Benzodiazepines / adverse effects
• Benzodiazepines / therapeutic use
• Contract Services / legislation & jurisprudence
• Cooperative Behavior
• Drug Utilization
• Germany
• Guideline Adherence / legislation & jurisprudence
• Humans
• Hypnotics and Sedatives / therapeutic use*
• Iatrogenic Disease
• Insurance, Health / legislation & jurisprudence*
• Insurance, Pharmaceutical Services / legislation & jurisprudence*
• Interdisciplinary Communication
• Long-Term Care / legislation & jurisprudence
• National Health Programs / legislation & jurisprudence*
• Off-Label Use / legislation & jurisprudence
• Piperazines / adverse effects
• Piperazines / therapeutic use
• Practice Patterns, Physicians' / legislation & jurisprudence*
• Primary Health Care / legislation & jurisprudence*
• Pyridines / adverse effects
• Pyridines / therapeutic use
• Substance-Related Disorders / etiology
• Substance-Related Disorders / prevention & control
• Zolpidem